HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radioactive waste discharge quantities for patients undergoing radioactive iodine therapy for thyroid carcinoma.

Abstract
There is a need to provide realistic estimates of the activity discharged to the drains by patients undergoing procedures involving unsealed radionuclides. These estimates are essential for record keeping purposes, to demonstrate compliance with limits set in waste disposal authorizations and for planning new installations. In this study, we report the discharge of activity for 174 patients (202 treatments) undergoing treatment of thyroid carcinoma with radioactive iodine. We have found that approximately 55% of administered activity is excreted in the first 24 h and that 85% of administered activity is discharged to the sewer over a typical inpatient stay of 5 days. There was no significant difference in levels of discharge between those patients undergoing inaugural ablation therapy and those having further treatments with radioactive iodine.
AuthorsI Driver, S Packer
JournalNuclear medicine communications (Nucl Med Commun) Vol. 22 Issue 10 Pg. 1129-32 (Oct 2001) ISSN: 0143-3636 [Print] England
PMID11567187 (Publication Type: Journal Article)
Chemical References
  • Iodine Radioisotopes
  • Medical Waste
  • Radioactive Waste
Topics
  • Iodine Radioisotopes
  • Medical Waste (analysis)
  • Radioactive Waste (analysis)
  • Radiometry
  • Thyroid Neoplasms (radiotherapy)
  • United States
  • United States Environmental Protection Agency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: